Study of ONO-2506 in Patients With Acute Ischemic Stroke

Controlled Study of ONO-2506 in Patients With Acute Ischemic Stroke

The purpose of this study is to determine the efficacy and safety of ONO-2506 compared to placebo in patients with acute ischemic stroke.

Inclusion Criteria:

1. Subjects who have a clinical diagnosis of acute ischemic stroke
2. Subjects within 72 hours after onset of the stroke
3. Other inclusion criteria may apply.

Exclusion Criteria:

1. Subjects who are scheduled to have surgical operations likely to affect the prognosis (including intravascular surgery and circulatory reconstruction)
2. Subjects who are pregnant or lactating, or who have child-bearing potential, or who wish to become pregnant.
3. Other exclusion criteria may apply.